BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25323227)

  • 1. Asthma, airflow limitation and mortality risk in the general population.
    Huang S; Vasquez MM; Halonen M; Martinez FD; Guerra S
    Eur Respir J; 2015 Feb; 45(2):338-46. PubMed ID: 25323227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic significance of lung function in stable heart failure outpatients.
    Plesner LL; Dalsgaard M; Schou M; Køber L; Vestbo J; Kjøller E; Iversen K
    Clin Cardiol; 2017 Nov; 40(11):1145-1151. PubMed ID: 28902960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study.
    Torén K; Andersson M; Olin AC; Blanc PD; Järvholm B
    Respir Med; 2018 Nov; 144():36-41. PubMed ID: 30366582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort.
    Baarnes CB; Thuesen BH; Linneberg A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():713-718. PubMed ID: 30988605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV
    Saint-Pierre M; Ladha J; Berton DC; Reimao G; Castelli G; Marillier M; Bernard AC; O'Donnell DE; Neder JA
    Chest; 2019 Sep; 156(3):497-506. PubMed ID: 30768928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
    Bhatt SP; Balte PP; Schwartz JE; Cassano PA; Couper D; Jacobs DR; Kalhan R; O'Connor GT; Yende S; Sanders JL; Umans JG; Dransfield MT; Chaves PH; White WB; Oelsner EC
    JAMA; 2019 Jun; 321(24):2438-2447. PubMed ID: 31237643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating biomarkers of airflow limitation across the life span.
    Zhai J; Voraphani N; Imboden M; Keidel D; Liu C; Stern DA; Venker C; Petersen H; Bosco A; Sherrill DL; Morgan WJ; Tesfaigzi Y; Probst-Hensch NM; Martinez FD; Halonen M; Guerra S
    J Allergy Clin Immunol; 2024 Jun; 153(6):1692-1703. PubMed ID: 38253260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
    Holt NR; Thompson BR; Miller B; Borg BM
    Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between risk of airflow limitation and serum uric acid measured at medical health check-ups.
    Fukuhara A; Saito J; Sato S; Saito K; Fukuhara N; Tanino Y; Wang X; Rinno K; Suzuki H; Munakata M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1213-1219. PubMed ID: 28458533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course of persistent airflow limitation in subjects with and without asthma.
    Guerra S; Sherrill DL; Kurzius-Spencer M; Venker C; Halonen M; Quan SF; Martinez FD
    Respir Med; 2008 Oct; 102(10):1473-82. PubMed ID: 18684603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airflow limitation more than doubles the risk for hospitalization/mortality in patients with heart failure.
    Bugajski A; Frazier SK; Moser DK; Chung M; Lennie TA
    Eur J Cardiovasc Nurs; 2019 Mar; 18(3):245-252. PubMed ID: 30607982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism.
    Shin SH; Kang D; Cho J; Chang H; Kim MS; Lee SY; Lee H; Kim H; Kim DK; Kim EK; Park HY
    Int J Chron Obstruct Pulmon Dis; 2018; 13():937-943. PubMed ID: 29593386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults.
    Turkeshi E; Vaes B; Andreeva E; Matheï C; Adriaensen W; Van Pottelbergh G; Degryse JM
    Eur Respir J; 2015 Jul; 46(1):123-32. PubMed ID: 25882799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk.
    Guerra S; Sherrill DL; Venker C; Ceccato CM; Halonen M; Martinez FD
    Thorax; 2009 Oct; 64(10):894-900. PubMed ID: 19581277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and self-rated health of overlap syndrome.
    Chung JW; Kong KA; Lee JH; Lee SJ; Ryu YJ; Chang JH
    Int J Chron Obstruct Pulmon Dis; 2014; 9():795-804. PubMed ID: 25092973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.